Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06617741 · ClinicalTrials.gov registry record
Myasthenia Gravis Foundation of America Global MG Patient Registry
A clinical trial of Myasthenia Gravis, Generalized and Myasthaenia Gravis, sponsored by Myasthenia Gravis Foundation of America.
- Recruiting
- Registry status
- 3,800
- Enrollment target
- 1
- Study location
NCT06617741 is a study of Myasthenia Gravis, Generalized and Myasthaenia Gravis that is actively recruiting participants, run by Myasthenia Gravis Foundation of America. The registered enrollment target is 3,800 participants, above the 71-participant average among 3 other Myasthenia Gravis, Generalized trials with a reported enrollment target (5252% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06617741, a study of Myasthenia Gravis, Generalized and Myasthaenia Gravis, is actively recruiting participants, sponsored by Myasthenia Gravis Foundation of America.
- RECRUITING
- Registry status
- 3,800 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are: * How and when are people with MG diagnosed? * What are the most common symptoms associated with MG? * What treatments are being used to treat MG? * What are the impacts of MG on activities of daily living, employment and quality of life? * What are the experiences with exacerbation, hospitalization and healthcare access for people with MG? Participants will answer a survey to enroll in the study, and be invited to fill out an update survey twice a year.
Conditions Studied
Study Locations (1)
Massachusetts
- Myasthenia Gravis Foundation of America - Westborough
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,800 participants |
| Start Date | 2013-10-12 |
| Est. Completion | 2029-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06617741
The ClinicalTrials.gov registry entry for NCT06617741 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 3 other Myasthenia Gravis, Generalized trials with a reported enrollment target (5252% higher). The listed sponsor is Myasthenia Gravis Foundation of America, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Myasthenia Gravis, Generalized appearing as the primary indexed condition, and to 0 interventions.
NCT06617741 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06617741 about?
NCT06617741 is a clinical study titled "Myasthenia Gravis Foundation of America Global MG Patient Registry". The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are: * How and when are people with MG diagnosed? * What are the most common symptoms associated with MG? * What treatments ...
What is the current status of trial NCT06617741?
This trial is currently recruiting. The enrollment target is 3,800 participants. The study started on 2013-10-12. Estimated completion is 2029-09-19.
What conditions does trial NCT06617741 study?
This clinical trial studies the following conditions: Myasthenia Gravis, Generalized, Myasthaenia Gravis, Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations, Myasthenia Gravis, Ocular.
Who is sponsoring clinical trial NCT06617741?
This trial is sponsored by Myasthenia Gravis Foundation of America, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06617741 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis, Generalized
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
ACTIVE NOT RECRUITING · Phase 3
-
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
ACTIVE NOT RECRUITING · Phase 2
-
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.